First Trust Advisors’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $424K | Sell |
1,522
-55,710
| -97% | -$16M | ﹤0.01% | 2384 |
|
|
2025
Q4 | $17.3M | Buy |
57,232
+56,012
| +4,591% | +$17.5M | 0.01% | 917 |
|
|
2025
Q3 | $342K | Buy |
1,220
+100
| +9% | +$27.2K | ﹤0.01% | 2388 |
|
|
2025
Q2 | $270K | Buy |
+1,120
| New | +$265K | ﹤0.01% | 2446 |
|
|
2025
Q1 | – | Sell |
-1,093
| Closed | -$359K | – | 2541 |
|
|
2024
Q4 | $359K | Sell |
1,093
-17,163
| -94% | -$5.83M | ﹤0.01% | 2334 |
|
|
2024
Q3 | $6.11M | Buy |
+18,256
| New | +$5.8M | 0.01% | 1234 |
|
|
2022
Q4 | – | Sell |
-2,917
| Closed | -$1.22M | – | 2429 |
|
|
2022
Q3 | $1.22M | Sell |
2,917
-86,664
| -97% | -$43.2M | ﹤0.01% | 1919 |
|
|
2022
Q2 | $44.3M | Buy |
89,581
+21,783
| +32% | +$11.3M | 0.05% | 475 |
|
|
2022
Q1 | $38.2M | Sell |
67,798
-286
| -0.4% | -$172K | 0.04% | 566 |
|
|
2021
Q4 | $51.4M | Buy |
68,084
+3,732
| +6% | +$2.79M | 0.05% | 489 |
|
|
2021
Q3 | $48M | Buy |
64,352
+6,912
| +12% | +$5.18M | 0.05% | 472 |
|
|
2021
Q2 | $37M | Sell |
57,440
-4,306
| -7% | -$2.62M | 0.04% | 545 |
|
|
2021
Q1 | $35.3M | Sell |
61,746
-250,967
| -80% | -$149M | 0.04% | 515 |
|
|
2020
Q4 | $182M | Buy |
312,713
+19,110
| +7% | +$10.9M | 0.24% | 111 |
|
|
2020
Q3 | $151M | Sell |
293,603
-16,296
| -5% | -$8.25M | 0.24% | 98 |
|
|
2020
Q2 | $140M | Buy |
309,899
+258,400
| +502% | +$114M | 0.24% | 99 |
|
|
2020
Q1 | $18.1M | Sell |
51,499
-23,519
| -31% | -$8.65M | 0.04% | 512 |
|
|
2019
Q4 | $27.8M | Buy |
75,018
+2,741
| +4% | +$966K | 0.05% | 510 |
|
|
2019
Q3 | $24M | Sell |
72,277
-28,184
| -28% | -$9.19M | 0.05% | 514 |
|
|
2019
Q2 | $31.4M | Sell |
100,461
-93,139
| -48% | -$27.9M | 0.06% | 436 |
|
|
2019
Q1 | $59.2M | Buy |
193,600
+6,976
| +4% | +$1.88M | 0.12% | 207 |
|
|
2018
Q4 | $43.3M | Buy |
186,624
+84,187
| +82% | +$22.6M | 0.1% | 246 |
|
|
2018
Q3 | $32.1M | Buy |
102,437
+94,894
| +1,258% | +$29.5M | 0.06% | 392 |
|
|
2018
Q2 | $2.18M | Buy |
+7,543
| New | +$2.08M | ﹤0.01% | 1581 |
|
|
2017
Q2 | – | Sell |
-24,935
| Closed | -$4.97M | – | 2373 |
|
|
2017
Q1 | $4.97M | Buy |
24,935
+21,960
| +738% | +$4.23M | 0.01% | 1052 |
|
|
2016
Q4 | $542K | Sell |
2,975
-73,671
| -96% | -$12.6M | ﹤0.01% | 2092 |
|
|
2016
Q3 | $12.6M | Sell |
76,646
-37,014
| -33% | -$5.62M | 0.04% | 640 |
|
|
2016
Q2 | $16.3M | Buy |
113,660
+65,785
| +137% | +$9.38M | 0.05% | 498 |
|
|
2016
Q1 | $6.54M | Sell |
47,875
-69,937
| -59% | -$9.18M | 0.02% | 844 |
|
|
2015
Q4 | $16.3M | Buy |
117,812
+109,302
| +1,284% | +$15.2M | 0.04% | 487 |
|
|
2015
Q3 | $1.14M | Sell |
8,510
-128,679
| -94% | -$18.5M | ﹤0.01% | 1680 |
|
|
2015
Q2 | $20.7M | Buy |
137,189
+5,874
| +4% | +$840K | 0.05% | 416 |
|
|
2015
Q1 | $17.8M | Buy |
131,315
+120,598
| +1,125% | +$14.9M | 0.05% | 472 |
|
|
2014
Q4 | $1.29M | Sell |
10,717
-80,661
| -88% | -$9.28M | ﹤0.01% | 1643 |
|
|
2014
Q3 | $10.4M | Buy |
91,378
+15,687
| +21% | +$1.86M | 0.04% | 696 |
|
|
2014
Q2 | $9.06M | Sell |
75,691
-66,721
| -47% | -$8.15M | 0.04% | 712 |
|
|
2014
Q1 | $18.2M | Sell |
142,412
-26,334
| -16% | -$3.38M | 0.08% | 363 |
|
|
2013
Q4 | $20.9M | Buy |
168,746
+29,501
| +21% | +$3.59M | 0.1% | 257 |
|
|
2013
Q3 | $16.4M | Buy |
139,245
+24,623
| +21% | +$2.9M | 0.09% | 327 |
|
|
2013
Q2 | $12.9M | Buy |
+114,622
| New | +$13.4M | 0.08% | 341 |
|
Other funds holding BIO
VCM
VPM
AI
